{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-056039","form_type":"8-K","ticker":"PLUR","cik":"0001158780","company_name":"Pluri Inc.","filed_at":"2023-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.254369+00:00","generated_at":"2026-06-13T09:47:51.736792+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pluri signs $4.2M NIAID contract to develop PLX-R18 cell therapy for H-ARS","bullets":["Three-year, $4.2M contract with NIAID to advance PLX-R18 for Hematopoietic Acute Radiation Syndrome (H-ARS).","Company will collaborate with U.S. DOD's AFRRI and Uniformed Services University of Health Sciences (USUHS).","Program funded by NIAID, part of the National Institutes of Health (NIH).","PLX-R18 is a potential novel treatment for radiation exposure from nuclear disasters."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-056039","json":"https://secwatch.observer/filing/0001213900-23-056039.json","markdown":"https://secwatch.observer/filing/0001213900-23-056039.md","text":"https://secwatch.observer/filing/0001213900-23-056039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158780/000121390023056039/0001213900-23-056039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158780/000121390023056039/ea181617-8k_pluriinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:47:51.736792+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}